Market Overview:
The global home use lancing devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, growing awareness about self-monitoring of blood glucose levels, and technological advancements in lancing devices. Based on type, the global home use lancing devices market is segmented into adjustable lancing device and non-adjustable lancing device. The adjustable lancing device segment is expected to grow at a higher CAGR than the non-adjustable lancing device segment during the forecast period from 2018 to 2030. This can be attributed to its features such as easy adjustment of depth and angle for piercing skin, which makes it suitable for people with different skin types. Based on application, the global home use lancet devices market is divided into cholesterol tests, glucose tests, and others (includes hemoglobin A1c test).
Product Definition:
A home use lancing device is a medical device used to prick the skin in order to obtain a blood sample for diagnostic testing. The importance of home use lancing devices is that they allow people with diabetes to monitor their blood sugar levels at home, which can help them avoid dangerous spikes and lows in their blood sugar levels. Home use lancing devices are also important because they allow people with diabetes to track their progress over time, which can help them better manage their condition.
Adjustable Lancing Device:
An adjustable lancing device is a medical device used for the administration of insulin, vaccines, blood thinner or any other injectable drug. It's basically an injection pen with a dial on it that allows the user to control how much medication goes in based on how hard you press down on it. The most common type of adjustble lancinig devices are prefilled syringes and vials/syringes with built-in scales.
Non-adjustable Lancing Device:
Non-adjustable lancing device is a medical device used for the administration of insulin through injection. It is also known as home use lancing device and penjet injector. The non-adjustable lancet consists of a thin metal or plastic tube with one or more sharpened needles attached to it, which can be inserted into the skin to extract blood. This blood sample is then sent to lab for testing purposes.
Application Insights:
Based on the application, the market is segmented into cholesterol tests, glucose tests, blood gas analyzer lancing devices, and others. The cholesterol tests segment dominated the global market in 2017 owing to a rise in demand for home use lancing devices from individuals who are concerned about their health and wellness. A rise in awareness regarding cardiovascular diseases coupled with an increase in disposable income has led to an increased number of people opting for these types of testing at home.
The blood gas analyzer lancing device is anticipated to be the fastest-growing application over the forecast period due to its wide applications across various diagnostic laboratories worldwide. It is used as a tool for measuring electrolyte levels such as sodium chloride (salt), calcium (calcium), bicarbonate (bicarbonate) and phosphate (phosphate). These electrolyte levels are important because they affect several body functions including heart rate, digestion process of foodstuffs etc.
Regional Analysis:
North America dominated the global home use lancing devices market in 2017. This can be attributed to the presence of a large number of players in this region, which is actively involved in strategic initiatives such as new product development and distribution alliances. The U.S., being one of the most developed countries, has a well-established healthcare infrastructure that enables people to avail various medical treatments at affordable costs.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of diabetes.
Growth Factors:
- Increasing prevalence of diabetes and other blood-sugar related disorders.
- Growing awareness about the benefits of home use lancing devices over traditional finger pricking methods.
- Technological advancements in home use lancing devices that make them easier and more comfortable to use.
- Rising demand for convenience and portability in personal healthcare products.
- Increasing affordability of home use lancing devices due to declining manufacturing costs
Scope Of The Report
Report Attributes
Report Details
Report Title
Home Use Lancing Devices Market Research Report
By Type
Adjustable Lancing Device, Non-adjustable Lancing Device
By Application
Cholesterol Tests, Glucose Tests, Others
By Companies
Roche, LifeScan, Abbott, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, GMMC, BIONIME
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Home Use Lancing Devices Market Report Segments:
The global Home Use Lancing Devices market is segmented on the basis of:
Types
Adjustable Lancing Device, Non-adjustable Lancing Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cholesterol Tests, Glucose Tests, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- LifeScan
- Abbott
- Ascensia
- B. Braun
- Terumo
- ARKRAY
- Trividia Health
- SANNUO
- GMMC
- BIONIME
Highlights of The Home Use Lancing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Adjustable Lancing Device
- Non-adjustable Lancing Device
- By Application:
- Cholesterol Tests
- Glucose Tests
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Home Use Lancing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Home use lancing devices are medical devices that are used to remove small blood clots from the body. They work by using a small, sharp object to break up the clot and then removing it through a vein.
Some of the major players in the home use lancing devices market are Roche, LifeScan, Abbott, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, GMMC, BIONIME.
The home use lancing devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Home Use Lancing Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Home Use Lancing Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Home Use Lancing Devices Market - Supply Chain
4.5. Global Home Use Lancing Devices Market Forecast
4.5.1. Home Use Lancing Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Home Use Lancing Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Home Use Lancing Devices Market Absolute $ Opportunity
5. Global Home Use Lancing Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Home Use Lancing Devices Market Size and Volume Forecast by Type
5.3.1. Adjustable Lancing Device
5.3.2. Non-adjustable Lancing Device
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Home Use Lancing Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Home Use Lancing Devices Market Size and Volume Forecast by Application
6.3.1. Cholesterol Tests
6.3.2. Glucose Tests
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Home Use Lancing Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Home Use Lancing Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Home Use Lancing Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Home Use Lancing Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Home Use Lancing Devices Demand Share Forecast, 2019-2029
9. North America Home Use Lancing Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Home Use Lancing Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Home Use Lancing Devices Market Size and Volume Forecast by Application
9.4.1. Cholesterol Tests
9.4.2. Glucose Tests
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Home Use Lancing Devices Market Size and Volume Forecast by Type
9.7.1. Adjustable Lancing Device
9.7.2. Non-adjustable Lancing Device
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Home Use Lancing Devices Demand Share Forecast, 2019-2029
10. Latin America Home Use Lancing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Home Use Lancing Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Home Use Lancing Devices Market Size and Volume Forecast by Application
10.4.1. Cholesterol Tests
10.4.2. Glucose Tests
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Home Use Lancing Devices Market Size and Volume Forecast by Type
10.7.1. Adjustable Lancing Device
10.7.2. Non-adjustable Lancing Device
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Home Use Lancing Devices Demand Share Forecast, 2019-2029
11. Europe Home Use Lancing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Home Use Lancing Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Home Use Lancing Devices Market Size and Volume Forecast by Application
11.4.1. Cholesterol Tests
11.4.2. Glucose Tests
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Home Use Lancing Devices Market Size and Volume Forecast by Type
11.7.1. Adjustable Lancing Device
11.7.2. Non-adjustable Lancing Device
11.8. Basis Poit Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Home Use Lancing Devices Demand Share, 2019-2029
12. Asia Pacific Home Use Lancing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Home Use Lancing Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Home Use Lancing Devices Market Size and Volume Forecast by Application
12.4.1. Cholesterol Tests
12.4.2. Glucose Tests
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Home Use Lancing Devices Market Size and Volume Forecast by Type
12.7.1. Adjustable Lancing Device
12.7.2. Non-adjustable Lancing Device
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Home Use Lancing Devices Demand Share, 2019-2029
13. Middle East & Africa Home Use Lancing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Home Use Lancing Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Home Use Lancing Devices Market Size and Volume Forecast by Application
13.4.1. Cholesterol Tests
13.4.2. Glucose Tests
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Home Use Lancing Devices Market Size and Volume Forecast by Type
13.7.1. Adjustable Lancing Device
13.7.2. Non-adjustable Lancing Device
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Home Use Lancing Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Home Use Lancing Devices Market: Market Share Analysis
14.2. Home Use Lancing Devices Distributors and Customers
14.3. Home Use Lancing Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. LifeScan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ascensia
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. B. Braun
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Terumo
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ARKRAY
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Trividia Health
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SANNUO
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GMMC
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BIONIME
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
